论文信息 - Pretransplant pharmacokinetics: does it predict the dose of tacrolimus after renal transplantation? - 字舞流文

Pretransplant pharmacokinetics: does it predict the dose of tacrolimus after renal transplantation?

M. Christiaans | N. Undre | J. V. van Hooff | J. Boots

[1] V. Armstrong,et al. Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients. , 2001, Transplantation proceedings.

[2] C. Shek,et al. Abbreviated tacrolimus area-under-the-curve monitoring for renal transplant recipients. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3] N. Undre,et al. Pharmacokinetics of tacrolimus: clinically relevant aspects. , 1999, Transplantation proceedings.

[4] J. Hooff,et al. Low systemic exposure to tacrolimus correlates with acute rejection. , 1999, Transplantation proceedings.

[5] R. Kershner,et al. Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. , 1996, Transplantation.

[6] A. Matas,et al. Phase II FK 506 multicenter concentration control study: one-year follow-up. , 1995, Transplantation proceedings.

[7] T. Starzl,et al. Pharmacokinetics of FK 506 in transplant patients. , 1991, Transplantation proceedings.

[8] N. Undre,et al. Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group. , 1998, Transplantation proceedings.